HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Tarr, K. Articles by Longmore, G. D. Search for Related Content PubMed PubMed Citation Articles by Tarr, K. Articles by Longmore, G. D. Social Bookmarking                      What's this?

Volume 272, Number 14, Issue of April 4, 1997 pp. 9099-9107
©1997 by The American Society for Biochemistry and Molecular Biology, Inc.

---

Cell Surface Organization of the Erythropoietin Receptor Complex Differs Depending on its Mode of Activation

(Received for publication, September 25, 1996, and in revised form, December 23, 1996)

Kathleen Tarr , Stephanie S. Watowich ^§ and Gregory D. Longmore ^¶

From the Departments of  Medicine and ^¶ Cell Biology, Washington University School of Medicine, St. Louis, Missouri 63110 and ^§ Department of Immunology, M. D. Anderson Cancer Center, Houston, Texas 77030

During erythroid development erythropoietin (EPO) binds specifically to a receptor primarily present on committed erythroid progenitors, stimulating mitogenic, survival, and differentiative growth response pathways. Other modes of erythropoietin receptor (EPO-R) activation, such as interaction with the env gene Friend virus envelope glycoprotein (F-gp55) of spleen focus-forming virus or specific mutations in the extracellular domain of the EPO-R, give rise to pathological consequences, in vivo and EPO-independent proliferation and differentiation of cultured cells. Activating extracellular receptor mutations result in covalently linked receptor homodimers. These observations and others have led to the proposal that EPO activates the EPO-R by inducing dimer formation on the cell surface. It has been assumed that F-gp55 also induces dimer formation of the EPO-R; however, clear evidence of this is lacking. In addition, EPO and F-gp55 stimulation of the EPO-R elicit different biological responses. To probe whether the cell surface EPO-R is structurally different with these activators, we contrasted the cell surface EPO-R complex formed following receptor activation by EPO, F-gp55, and mutations in the extracellular domain of the receptor. Our results indicate that cell surface forms of activated EPO-R differ, as judged by their differential association with F-gp55 and pattern of associated cell surface proteins. Interestingly, we find that the env gene of an anemic strain of Friend virus, Rauscher virus envelope glycoprotein, does not interact with the EPO-R at the cell surface. Thus, the mode of Rauscher virus envelope glycoprotein-induced erythroblastosis may be distinct from F-gp55-induced erythroblastosis and possibly not involve the EPO-R.

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				W. Ruan, V. Becker, U. Klingmuller, and D. Langosch The Interface between Self-assembling Erythropoietin Receptor Transmembrane Segments Corresponds to a Membrane-spanning Leucine Zipper J. Biol. Chem., January 30, 2004; 279(5): 3273 - 3279. [Abstract] [Full Text] [PDF]

				S. N. Constantinescu, T. Keren, W. P. Russ, I. Ubarretxena-Belandia, Y. Malka, K. F. Kubatzky, D. M. Engelman, H. F. Lodish, and Y. I. Henis The Erythropoietin Receptor Transmembrane Domain Mediates Complex Formation with Viral Anemic and Polycythemic gp55 Proteins J. Biol. Chem., October 31, 2003; 278(44): 43755 - 43763. [Abstract] [Full Text] [PDF]

				T. Naranda, R. I. Kaufman, J. Li, K. Wong, A. Boge, D. Hallen, K. Y. C. Fung, M. W. Duncan, N. Andersen, A. Goldstein, et al. Activation of Erythropoietin Receptor through a Novel Extracellular Binding Site Endocrinology, June 1, 2002; 143(6): 2293 - 2302. [Abstract] [Full Text] [PDF]

				P. A. Ney and A. D. D'Andrea Friend erythroleukemia revisited Blood, December 1, 2000; 96(12): 3675 - 3680. [Full Text] [PDF]

				R. Gurezka, R. Laage, B. Brosig, and D. Langosch A Heptad Motif of Leucine Residues Found in Membrane Proteins Can Drive Self-assembly of Artificial Transmembrane Segments J. Biol. Chem., April 2, 1999; 274(14): 9265 - 9270. [Abstract] [Full Text] [PDF]

				S. S. Watowich, K. D. Liu, X. Xie, S. Y. Lai, A. Mikami, G. D. Longmore, and M. A. Goldsmith Oligomerization and Scaffolding Functions of the Erythropoietin Receptor Cytoplasmic Tail J. Biol. Chem., February 26, 1999; 274(9): 5415 - 5421. [Abstract] [Full Text] [PDF]

				S. N. Constantinescu, H. Wu, X. Liu, W. Beyer, A. Fallon, and H. F. Lodish The Anemic Friend Virus gp55 Envelope Protein Induces Erythroid Differentiation in Fetal Liver Colony-Forming Units-Erythroid Blood, February 15, 1998; 91(4): 1163 - 1172. [Abstract] [Full Text] [PDF]